Counter views welcome Phlipper. Any delaying effect on the trials due to the virus will be one of risk assessment. Many factors will come into play, obviously dominated by the spread of the virus in the US and the general policy framework implemented to combat this.
ACADIA's main preoccupation here will be the assessment of risks to the girls and protection of the integrity of the trials, which of course will be multifaceted. I am sure top level discussions in this regard are already well underway.
This unfortunate event is going to effect many of the processes which govern everyday lives and, IMO, to think that our trial will come out unscathed is rather naive. I guess, that at this stage, the degree of any disruption is still speculation.
Ann: Appendix 4E and 2019 full year accounts, page-94
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.99 |
Change
0.540(2.64%) |
Mkt cap ! $2.682B | |||
| Open | High | Low | Value | Volume |
| $20.56 | $21.55 | $20.54 | $12.48M | 591.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 435 | $20.97 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.99 | 1001 | 2 |
View Market Depth
| Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |